The purpose of a clinical study is to test new medicines in people living with specific diseases to help researchers understand their potential effect and safety for use in individuals with the condition.1
Phase 1 is the first clinical study to be done. It tests the safety of the investigational drug in humans for the first time. This is usually done in healthy volunteers without the disease.2
More than 150 healthy volunteers took cenerimod during the Phase 1 clinical studies.3,4,5,6,7,8
Phase 2 aims to establish the efficacy and safety of the investigational drug in people living with the disease and possibly the best dose of the investigational drug (how much) to give people.2
More than 400 people with SLE took cenerimod during the Phase 2 studies.9,10
Phase 3 is done to evaluate if the investigational drug works in a larger number of people living with the disease.2
The OPUS clinical study is in this phase.
Philippines 
日本語 